These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8864317)

  • 81. Influence of biological variables upon pharmacokinetic parameters of intramuscular methotrexate in rheumatoid arthritis.
    Debord J; Carpentier N; Sabot C; Bertin P; Marquet P; Treves R; Merle L; Lachâtre G
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):227-30. PubMed ID: 9587050
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Nonadherence to disease modifying antirheumatic drugs in the first year after diagnosis: comparing three adherence measures in early arthritis patients.
    Pasma A; den Boer E; van 't Spijker A; Timman R; van den Bemt B; Busschbach JJ; Hazes JM
    Rheumatology (Oxford); 2016 Oct; 55(10):1812-9. PubMed ID: 27354686
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration.
    Bianchi G; Caporali R; Todoerti M; Mattana P
    Adv Ther; 2016 Mar; 33(3):369-78. PubMed ID: 26846283
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational study.
    Aletaha D; Stamm T; Kapral T; Eberl G; Grisar J; Machold KP; Smolen JS
    Ann Rheum Dis; 2003 Oct; 62(10):944-51. PubMed ID: 12972472
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    J Rheumatol; 2002 May; 29(5):883-9. PubMed ID: 12022344
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Investigation of Potential Drug-Drug Interactions between Peficitinib (ASP015K) and Methotrexate in Patients with Rheumatoid Arthritis.
    Zhu T; Moy S; Valluri U; Cao Y; Zhang W; Sawamoto T; Chindalore V; Akinlade B
    Clin Drug Investig; 2020 Sep; 40(9):827-838. PubMed ID: 32591978
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis.
    Hamilton RA; Kremer JM
    Br J Rheumatol; 1997 Jan; 36(1):86-90. PubMed ID: 9117183
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Methotrexate improves the anti-arthritic effects of Paeoniflorin-6'-O-benzene sulfonate by enhancing its pharmacokinetic properties in adjuvant-induced arthritis rats.
    Asenso J; Yu J; Xiao F; Zhao M; Wang J; Wu Y; Wang C; Wei W
    Biomed Pharmacother; 2019 Apr; 112():108644. PubMed ID: 30798135
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis.
    Godfrey C; Sweeney K; Miller K; Hamilton R; Kremer J
    Br J Clin Pharmacol; 1998 Oct; 46(4):369-76. PubMed ID: 9803986
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Methotrexate Triglutamate as a Determinant of Clinical Response in Mexican Patients With Rheumatoid Arthritis: Pharmacokinetics and Dose Recommendation.
    Huerta-García AP; Rodríguez-Báez AS; Medellín-Garibay SE; Portales-Pérez DP; Martínez-Martínez MU; Abud-Mendoza C; Herrera-Van Oostdam D; Romano-Moreno S; Milán-Segovia RDC
    J Clin Pharmacol; 2021 Aug; 61(8):1118-1130. PubMed ID: 33595870
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Sulphasalazine alone or in combination with D-penicillamine in rheumatoid arthritis.
    Taggart AJ; Hill J; Astbury C; Dixon JS; Bird HA; Wright V
    Br J Rheumatol; 1987 Feb; 26(1):32-6. PubMed ID: 2880632
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Pharmacokinetic studies of methotrexate in plasma and synovial fluid following i.v. bolus and topical routes of administration in dogs.
    Lu GW; Jun HW; Dzimianski MT; Qiu HC; McCall JW
    Pharm Res; 1995 Oct; 12(10):1474-7. PubMed ID: 8584484
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients.
    Herman RA; Veng-Pedersen P; Hoffman J; Koehnke R; Furst DE
    J Pharm Sci; 1989 Feb; 78(2):165-71. PubMed ID: 2715941
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis.
    Carmichael SJ; Charles B; Tett SE
    Ther Drug Monit; 2003 Dec; 25(6):671-81. PubMed ID: 14639053
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The effects of non-steroidal anti-inflammatory drugs on the disposition of methotrexate in patients with rheumatoid arthritis.
    Iqbal MP; Baig JA; Ali AA; Niazi SK; Mehboobali N; Hussain MA
    Biopharm Drug Dispos; 1998 Apr; 19(3):163-7. PubMed ID: 9569999
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Development and validation of a methotrexate adherence assay.
    Bluett J; Riba-Garcia I; Verstappen SMM; Wendling T; Ogungbenro K; Unwin RD; Barton A
    Ann Rheum Dis; 2019 Sep; 78(9):1192-1197. PubMed ID: 31167761
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Absence of Pharmacokinetic Interactions between the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib and Methotrexate.
    Jones NS; Winter H; Katsumoto TR; Florero M; Murray E; Walker H; Singh N; Chinn LW
    J Pharmacol Exp Ther; 2019 Oct; 371(1):202-207. PubMed ID: 31371481
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis.
    Chládek J; Grim J; Martínková J; Simková M; Vanìèková J; Koudelková V; Noièková M
    Br J Clin Pharmacol; 2002 Aug; 54(2):147-56. PubMed ID: 12207634
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Sulphasalazine in the treatment of children with chronic arthritis.
    Huang JL; Chen LC
    Clin Rheumatol; 1998; 17(5):359-63. PubMed ID: 9805178
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Erythrocyte-methotrexate and disease activity in children treated with oral methotrexate for juvenile chronic arthritis.
    Kristensen K; Nielsen S; Karup Pedersen F; Zak M
    Scand J Rheumatol; 2000; 29(3):187-9. PubMed ID: 10898073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.